Drug Development Clinical Trials Oncology Genomics Vaccines Gene Therapy Corporate Finance Immunoglobulin Cancer Treatment Corporate Strategies Research and Development Corporate Events Antibody Therapies Obesity Treatments Immunotherapy Inflammatory Diseases Industry Analysis Corporate Healthcare Company Performance Product Launch Publicly Traded Companies UroGen Pharma Regeneron Pharmaceuticals Vaccine Development Drug Discovery Combination Treatments Moderna Commercial-stage Biotech Biopharmaceuticals Immunology Rare Diseases Company News Multiple Sclerosis Treatments Regeneron Product Sales Market Trends Therapeutic Areas Diabetes Treatments Investment Opportunities Cardiovascular Treatments Stock Performance Mental Health
Income investors face a tough tradeoff over thin coverage of the payout.
